Upstream / Downstream

pathwayImage

Explore pathways related to this product.

Antibody Guarantee

CST Antibody Performance Guarantee

LEARN MORE  

To get local purchase information on this product, click here

Questions?

Find answers on our FAQs page.

ANSWERS  

Visit PhosphoSitePlus®

PTM information and tools available.

LEARN MORE

REACTIVITY SENSITIVITY MW (kDa) SOURCE
98 Rabbit

Product Usage Information

Storage: Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody.

Specificity / Sensitivity

PTPN22 Antibody recognizes endogenous levels of total PTPN22 protein.


Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding His301 of human PTPN22 protein. Antibodies are purified by protein A and peptide affinity chromatography.

PTPN22 (Lyp/PEP) is a cytoplasmic phosphatase expressed by hematopoietic cells (1,2). PTPN22 associates with the tyrosine kinase Csk to inhibit T cell receptor signaling through inactivation of Src kinases (3,4). Csk phosphorylates Src kinases on an inhibitory tyrosine, while PTPN22 dephosphorylates an activating site (4). PTPN22(-/-) mice have higher levels of activated Lck than wild-type, resulting in greater T cell expansion and increased serum antibody levels (5). Research studies have shown that a single-nucleotide polymorphism, 1858T of the PTPN22 gene which encodes the amino acid substitution R620W, confers increased risk for multiple autoimmune diseases including type I diabetes, rheumatoid arthritis, systemic lupus erythematosus, and Graves disease (6-9). Interestingly, although the R620W substitution disrupts the interaction between Csk and PTPN22, it is actually a gain-of-function mutation resulting in increased phosphatase activity (6,10,11). Recent evidence suggests that the autoimmune phenotype associated with the R620W variant is the result of increased calpain-mediated degradation and decreased protein levels of PTPN22 (12).


1.  Cohen, S. et al. (1999) Blood 93, 2013-24.

2.  Matthews, R.J. et al. (1992) Mol Cell Biol 12, 2396-405.

3.  Cloutier, J.F. and Veillette, A. (1996) EMBO J 15, 4909-18.

4.  Cloutier, J.F. and Veillette, A. (1999) J Exp Med 189, 111-21.

5.  Hasegawa, K. et al. (2004) Science 303, 685-9.

6.  Bottini, N. et al. (2004) Nat Genet 36, 337-8.

7.  Begovich, A.B. et al. (2004) Am J Hum Genet 75, 330-7.

8.  Kyogoku, C. et al. (2004) Am J Hum Genet 75, 504-7.

9.  Velaga, M.R. et al. (2004) J Clin Endocrinol Metab 89, 5862-5.

10.  Vang, T. et al. (2005) Nat Genet 37, 1317-9.

11.  Rieck, M. et al. (2007) J Immunol 179, 4704-10.

12.  Zhang, J. et al. (2011) Nat Genet 43, 902-7.


Entrez-Gene Id 26191
Swiss-Prot Acc. Q9Y2R2


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.